![]() | Only 14 pages are availabe for public view |
Abstract 1. To compare levels of synovial fluid soluble RANKL (sRANKL) between RA and Osteoarthritis (OA) patients. 2. To compare serum levels of sRANKL between RA, OA patients and the control subjects. 3. To find out if sRANKL is correlated with disease activity score (DAS), short erosion scale (SES) or with the treatment parameters in RA patients. |